Early dietary intervention: Long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 6 51-6, 2005, Pages

  Velkoska, Elena ^a   Cole, Timothy J ^b   Morris, Margaret J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

High fat diet; Leptin; Obesity; Postnatal overnutrition

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADIPONECTIN; BIOLOGICAL MARKER; INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY WEIGHT; BROWN ADIPOSE TISSUE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; DIET; FEEDING; FEMALE; HYPERTENSION; HYPOTHALAMUS; INSULIN BLOOD LEVEL; LIPID DIET; LITTER SIZE; MALE; MATURATION; NEWBORN; NONHUMAN; NUTRITION; OBESITY; OVERNUTRITION; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; RISK FACTOR; THALAMUS MIDLINE NUCLEUS; WEANING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPONECTIN; ADIPOSE TISSUE, BROWN; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; BLOTTING, NORTHERN; BODY WEIGHT; BRAIN; CARRIER PROTEINS; DIETARY FATS; FEMALE; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ION CHANNELS; LEPTIN; MALE; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; NEUROPEPTIDE Y; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19444364290     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00505.2004     Document Type: Article

References (56)

1. Argyropoulos G and Harper ME. Uncoupling proteins and thermoregulation. J Appl Physiol 92: 2187-2198, 2002.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
3. Babicky A, Ostadalova I, Parizek J, Kolar J, and Bibr B. Onset and duration of the physiological weaning period for infant rats reared in nests of different sizes. Physiol Bohemoslov 22: 449-456, 1973.
4. Bassett DR and Craig BW. Influence of early nutrition on growth and adipose tissue characteristics in male and female rats. J Appl Physiol 64: 1249-1256, 1988.
5. Caprio S, Hyman LD, McCarthy S, Lange R, Bronson M, and Tamborlane WV. Fat distribution and cardiovascular risk factors in obese adolescent girls: importance of the intraabdominal fat depot. Am J Clin Nutr 64: 12-17, 1996.
6. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, and Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17: 961-969, 1994.
7. Clark JT, Kalra PS, Crowley WR, and Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427-429, 1984.
8. Cole TJ, Harris HJ, Hoong I, Solomon N, Smith R, Krozowski Z, and Fullerton MJ. The glucocorticoid receptor is essential for maintaining basal and dexamethasone-induced repression of the murine corticosteroid-binding globulin gene. Mol Cell Endocrinol 154: 29-36, 1999.
9. Collins S and Surwit RS. Pharmacologic manipulation of ob expression in a dietary model of obesity. J Biol Chem 271: 9437-9440, 1996.
10. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, and Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295, 1996.
11. Del Mar Gonzalez-Barroso M, Ricquier D, and Cassard-Doulcier AM. The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research. Obes Rev 1: 61-72, 2000.
12. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101: 518-525, 1998.
13. Dobrian AD, Davies MJ, Prewitt RL, and Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension 35: 1009-1015, 2000.
14. Dunbar JC and Lu H. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull 50: 215-221, 1999.
15. Egawa M, Yoshimatsu H, and Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol Regul Integr Comp Physiol 260: R328-R334, 1991.
16. Faust IM, Johnson PR, and Hirsch J. Long-term effects of early nutritional experience on the development of obesity in the rat. J Nutr 110: 2027-2034, 1980.
17. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, and Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 317: 350-357, 1987.
18. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, and Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1: 1311-1314, 1995.
19. Fried SK, Ricci MR, Russell CD, and Laferrere B. Regulation of leptin production in humans. J Nutr 130: 3127S-3131S, 2000.
20. Kriedman JM and Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
21. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, and Davey Smith G. Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 67: 1111-1118, 1998.
22. Hahn TM, Breininger JF, Baskin DG, and Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1: 271-272, 1998.
23. Hansen MJ, Ball MJ, and Morris MJ. Enhanced inhibitory feeding response to α-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892: 130-137, 2001.
24. Hansen MJ, Jovanovska V, and Morris MJ. Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem 88: 909-916, 2004.
25. Hausberger FX and Volz JE. Feeding in infancy, adipose tissue cellularity and obesity. Physiol Behav 33: 81-87, 1984.
26. Haynes WG. Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep 2: 311-318, 2000.
27. Haynes WG, Morgan DA, Walsh SA, Mark AL, and Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100: 270-278, 1997.
28. Jeffreys M, McCarron P, Gunnell D, McEwen J, and Smith GD. Body mass index in early and mid-adulthood, and subsequent mortality: a historical cohort study. Int J Obes Relat Metab Disord 27: 1391-1397, 2003.
29. Kohn M and Booth M. The worldwide epidemic of obesity in adolescents. Adolesc Med 14: 1-9, 2003.
30. Landsberg L and Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 2: 125S-132S, 1989.
31. Liu X, Rossmeisl M, McClaine J, Riachi M, Harper ME, and Kozak LP. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J Clin Invest 111: 399-407, 2003.
32. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, and Walker BR. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141: 560-563, 2000.
33. Lonnqvist F, Nordfors L, Jansson M, Thorne A, Schalling M, and Arner P. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest 99: 2398-2404, 1997.
34. Lyon CJ, Law RE, and Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144: 2195-2200, 2003.
35. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, and Matsuzawa Y. Adiponectin in essential hypertension. J Nephrol 15: 507-511, 2002.
36. Mark AL, Correia M, Morgan DA, Shaffer RA, and Haynes WG. State-of-the-art-lecture: obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension 33: 537-541, 1999.
37. Martorell R, Stein AD, and Schroeder DG. Early nutrition and later adiposity. J Nutr 131: 874S-880S, 2001.
38. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, and Flier JS. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112: 83-90, 2003.
39. Michel MC and Rascher W. Neuropeptide Y: a possible role in hypertension? J Hypertens 13: 385-395, 1995.
40. Morris MJ, Hastings JA, and Pavia JM. Central interactions between noradrenaline and neuropeptide Y in the rat: implications for blood pressure control. Clin Exp Hypertens 19: 619-630, 1997.
41. Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM, and Chalmers JP. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv Syst 17: 143-149, 1986.
42. Myers MM, Handler-Matasar SR, and Shair HN. Effects of neonatal growth on adult blood pressures of borderline hypertensive rats. Hypertension 27: 96-101, 1996.
43. Naderali EK, Estadella D, Rocha M, Pickavance LC, Fatani S, Denis RG, and Williams G. A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue. Clin Sci (Lond) 105: 403-408, 2003.
44. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, and Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476, 1999.
45. Plagemann A, Harder T, Rake A, Voits M, Fink H, Rohde W, and Dorner G. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res 836: 146-155, 1999.
46. Plagemann A, Harder T, Rake A, Waas T, Melchior K, Ziska T, Rohde W, and Dorner G. Observations on the orexigenic hypothalamic neuropeptide Y system in neonatally overfed weanling rats. J Neuroendocrinol 11: 541-546, 1999.
47. Rajala MW and Scherer PE. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144: 3765-3773, 2003.
48. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, and Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87: 3330-3336, 2002.
49. Sahu A. Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 145: 2613-2620, 2004.
50. Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Ebihara K, Masuzaki H, Hosoda K, Yoshimasa Y, and Nakao K. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48: 1787-1793, 1999.
51. Shek EW, Brands MW, and Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 31: 409-414, 1998.
52. Shillabeer G, Vydelingum S, Hatch G, Russell JC, and Lau DC. Long-term regulation of leptin expression is correlated with adipocyte number in obese rats. Clin Invest Med 21: 54-62, 1998.
53. Slyper AH. The pediatric obesity epidemic: causes and controversies. J Clin Endocrinol Metab 89: 2540-2547, 2004.
54. Soumano K, Desbiens S, Rabelo R, Bakopanos E, Camirand A, and Silva JE. Glucocorticoids inhibit the transcriptional response of the uncoupling protein-1 gene to adrenergic stimulation in a brown adipose cell line. Mol Cell Endocrinol 165: 7-15, 2000.
55. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, and Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271, 1995.
56. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, and Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.